Chemoinformaics analysis of 3,6,7-trihydroxy-2-(4-hydroxy-3-methoxyphenyl)chromen-4-one
Molecular Weight | 1897.59 | nRot | 10 |
Heavy Atom Molecular Weight | 1825.01 | nRig | 18 |
Exact Molecular Weight | 1896.35 | nRing | 18 |
Solubility: LogS | -3.675 | nHRing | 6 |
Solubility: LogP | 2.318 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 18 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 210 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 138 | No. of Aromatic Carbocycles | 12 |
nHetero | 42 | No. of Aromatic Hetero Cycles | 6 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 72 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 96 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 96 |
No. of Oxygen atom | 42 | No. of Arom Bond | 102 |
nHA | 42 | APOL | 242.013 |
nHD | 26 | BPOL | 94.7989 |
QED | 0.535 |
Synth | 2.447 |
Natural Product Likeliness | 1.098 |
NR-PPAR-gamma | 0.933 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.009 |
Pgp-sub | 0.008 |
HIA | 0.02 |
CACO-2 | -5.016 |
MDCK | 0.0000107 |
BBB | 0.009 |
PPB | 0.927254 |
VDSS | 0.589 |
FU | 0.10252 |
CYP1A2-inh | 0.925 |
CYP1A2-sub | 0.534 |
CYP2c19-inh | 0.054 |
CYP2c19-sub | 0.05 |
CYP2c9-inh | 0.509 |
CYP2c9-sub | 0.605 |
CYP2d6-inh | 0.219 |
CYP2d6-sub | 0.287 |
CYP3a4-inh | 0.328 |
CYP3a4-sub | 0.11 |
CL | 10.158 |
T12 | 0.927 |
hERG | 0.039 |
Ames | 0.736 |
ROA | 0.137 |
SkinSen | 0.932 |
Carcinogencity | 0.084 |
EI | 0.932 |
Respiratory | 0.091 |
NR-Aromatase | 0.9 |
Antiviral | Yes |
Prediction | 0.649733 |